Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
100600
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise of stock acquisition rights with provisions for adjustment to the exercise price (monthly exercise status)
発行・処分する株式数
Shares delivered during the month: 100,600 (100,600 new shares; no transferred treasury shares stated)
発行済株式総数
Exercise ratio during the month: 1.35% (as a percentage of the total issued amount); exercise ratio subject to exercise restrictions: 0.34%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥212.0 on 2 October 2026 and 5 October 2026. Details of the adjustment clause and adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 74,682 rights (not a figure calculated from the statement that 1,006 rights represented 1.35% of the total issued amount; the text does not state the actual total issued). Unexercised balance at the end of the month preceding the relevant month: 33,684 rights; unexercised balance at month-end: 32,678 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with exercise restrictions pursuant to Article 434 of the Tokyo Stock Exchange Rules on Listing of Securities and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments.
Most recent equity financing
Issued on 30 March 2026: 7th Stock Acquisition Rights (with an exercise price adjustment clause)
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise of stock acquisition rights with provisions for adjustment to the exercise price (monthly exercise status) |
| Number of shares to be issued or disposed of | Shares delivered during the month: 100,600 (100,600 new shares; no transferred treasury shares stated) |
| Dilution Rate | Exercise ratio during the month: 1.35% (as a percentage of the total issued amount); exercise ratio subject to exercise restrictions: 0.34% |
| Total number of issued shares | 34,354,200 shares (as of the end of the month preceding the relevant month) → Not disclosed |
| Exercise price | ¥212.0 on 2 October 2026 and 5 October 2026. Details of the adjustment clause and adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 74,682 rights (not a figure calculated from the statement that 1,006 rights represented 1.35% of the total issued amount; the text does not state the actual total issued). Unexercised balance at the end of the month preceding the relevant month: 33,684 rights; unexercised balance at month-end: 32,678 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with exercise restrictions pursuant to Article 434 of the Tokyo Stock Exchange Rules on Listing of Securities and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments. |
| Most recent equity financing | Issued on 30 March 2026: 7th Stock Acquisition Rights (with an exercise price adjustment clause) |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the 7th Stock Acquisition Rights in October 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.